Images are for illustration purposes only

Wegovy® Oral Tablets (Semaglutide Pill)

1. Ozempic®️-equivalent therapy now available for weight management
2. Average weight loss of 17%, with 1 in 3 patients achieving over 20%
3. May help reduce osteoarthritis-related pain
4. Wegovy®️ is not expected to impact the effectiveness of oral contraceptives
5. Supports cardiovascular risk reduction
6. Over 22 million patients treated with semaglutide-based therapies since 2018

Price Checker

£83.00

Sale Sold out

Lowest price guarantee
Includes FREE private prescription

Quantity

View full details

● Priority Event: ORDER NOW

Wegovy® Oral Tablets

Daily Semaglutide Medication for Weight Management

Secure your position for the highly anticipated oral version of the active weight loss compound Semaglutide. Secure your pre-order allocations today with Cured Pharmacy to ensure prioritized clinical review, fast-tracked physician consultation, and immediate shipping upon product release.

✔ UK Registered Pharmacy ✔ Priority Order Allocation ✔ Secure Clinical Consultation

Reserve Allocation

Limited Batches

Pre-order allocations are now active. Reserve your treatment line today to secure priority access.

Estimated Dispatch NOW *Subject to final regulatory approval timelines. Full refunds available at any time prior to shipping.

Includes integrated online clinical safety review.

About Oral Semaglutide (Wegovy® Pill)

The development of an oral version of Wegovy® aims to expand accessibility for patients seeking effective weight management solutions without the requirement of a subcutaneous weekly injection. Powered by the GLP-1 receptor agonist Semaglutide, the treatment mimics the natural metabolic hormones responsible for controlling appetite, gastric emptying rates, and chemical food cravings.

Expected Clinical Characteristics

■

Non-Invasive Oral Method Eliminates needle-related barriers, offering a viable route for patients tracking long-term treatment lines without injection support.

■

Daily Dosing Regularity Formulated as a simple tablet taken once per day, matching typical chronic healthcare prescription profiles.

■

Metabolic Hormone Targets Maintains target efficacy pathways in the brain to reduce central baseline appetite, lower food noise, and provide prolonged fullness indicators.

Comparison: Oral Tablet vs. Weekly Injection

Parameters	Wegovy® Injection Formulation	Wegovy® Oral Tablet Profile
Active Compound	Semaglutide	Semaglutide
Route of Delivery	Subcutaneous Injection (Weekly)	Oral Tablet System (Daily)
Clinical Efficacy	Extensively verified baseline weight reduction	Clinical evaluations present matching weight reduction trends
Temperature Storage	Demands continuous cold refrigeration	Stable standard room temperature profile

Frequently Asked Questions

When will my pre-order be fulfilled and dispatched? ▼

Allocations secured during this pre-order window are scheduled to begin priority dispatch in early July, assuming final regulatory and supply chain stages clear as projected. If any delays arise, or if you choose to cancel before your clinical review, full refunds are issued immediately.

Will a prescription be required for this oral medication? ▼

Yes. Oral Semaglutide is classified strictly as a prescription-only medical treatment. Your pre-order reserves the medication batch; prior to dispatch, you will be fast-tracked through our online clinical consultation module for official assessment by our independent prescribing team.

Are side effects expected to differ from regular injections? ▼

Because the internal mechanism relies on the identical Semaglutide molecule, potential side-effect patterns closely resemble the injection. Common occurrences generally focus on gastrointestinal adjustments, such as nausea or digestive changes, which typically reduce as tracking timelines advance.